Activist Investor 13D Filings


This table shows recent activist investor (Schedule 13D) filings made in this industry. Any investor or hedge fund that makes an investment with the intention of influencing management is considered an activist investor and must file a 13D.

DateFormInvestorTargetSharesOwnership
(Percent)
Ownership Change
(Percent)
2018‑02‑16 SC 13D TVM Life Science Ventures VI LP ACER / Acer Therapeutics 2,397,309 32.0
2018‑02‑16 SC 13D/A 683 Capital Management, LLC ONTX / Onconova Therapeutics 4,664,934 21.8
2018‑02‑16 SC 13D 683 Capital Management, LLC ONTX / Onconova Therapeutics 4,664,934 21.8
2018‑02‑16 SC 13D/A ORBIMED ADVISORS LLC NTLA / Intellia Therapeutics 2,113,000 4.99 -16.74
2018‑02‑16 SC 13D/A Honig Barry C MBVX / MabVax Therapeutics Holdings 1,208,904 4.99 0.00
2018‑02‑15 SC 13D GREAT POINT PARTNERS LLC BCRX / BioCryst Pharmaceuticals 7,478,275 7.6
2018‑02‑15 SC 13D/A ORBIMED ADVISORS LLC XTNT / Xtant Medical Holdings 9,214,321 70.4 224.57
2018‑02‑15 SC 13D/A Kuno Sachiko SCMP / Sucampo Pharmaceuticals 0 0.0 -100.00
2018‑02‑15 SC 13D/A Ueno Ryuji SCMP / Sucampo Pharmaceuticals 0 0.0 -100.00
2018‑02‑14 SC 13D Meridian OHC Partners, LP CYAN / Cyanotech 749,610 13.3 0.00
2018‑02‑14 SC 13D/A CELGENE CORP /DE/ JUNO / Juno Therapeutics 11,109,160 9.7 0.00
2018‑02‑14 SC 13D/A Sofinnova Venture Partners VIII, L.P. MIRN / Mirna Therapeutics 574,972 2.7
2018‑02‑14 SC 13D/A SMITH ROBERT J TXMD / TherapeuticsMD 12,959,108 6.59
2018‑02‑14 SC 13D/A SOFINNOVA VENTURE PARTNERS VII L P CHRS / Coherus BioSciences 2,987,056 5.0 0.64
2018‑02‑14 SC 13D Sailing Capital Overseas Investments Fund, Lp CBMG / Cellular Biomedicine Group 1,712,920
2018‑02‑14 SC 13D/A KOSKI FAMILY LP OGEN / Oragenics 2,265,648 -86.63
2018‑02‑14 SC 13D/A MDV VII LP ADMS / Adamas Pharmaceuticals 46,197,962 20.6 0.00
2018‑02‑14 SC 13D/A ForArgos B.V. ARGS / Argos Therapeutics 9,012,326 11.43 0.00
2018‑02‑14 SC 13D/A THREE ARCH PARTNERS IV LP ACRX / AcelRx Pharmaceuticals 9,434,541 18.7 -2.58
2018‑02‑14 SC 13D/A Morgenthaler Partners VIII LP CBIO / Catalyst Biosciences 1,243 0.0 -99.86
2018‑02‑14 SC 13D/A Sofinnova Venture Partners VIII, L.P. ACRS / Aclaris Therapeutics 1,552,112 5.0 0.53
2018‑02‑14 SC 13D/A Roivant Sciences Ltd. ABUS / Arbutus Biopharma 16,013,540 29.1 0.00
2018‑02‑13 SC 13D/A Digirad Corp BOTA / Biota Pharmaceuticals 3,195,106 8.3 0.00
2018‑02‑13 SC 13D/A GLAXOSMITHKLINE PLC GNCA / Genocea Biosciences 2,121,668 2.6 0.00
2018‑02‑13 SC 13D Honig Barry C MBVX / MabVax Therapeutics Holdings 1,208,904 4.99 208.67
2018‑02‑13 SC 13D/A Honig Barry C RIOT / Riot Blockchain 173,432 1.47 -65.59
2018‑02‑12 SC 13D Stetson John MBVX / MabVax Therapeutics Holdings 1,204,352 4.99 40.91
2018‑02‑12 SC 13D/A Biotechnology Value Fund L P CTIC / CTI BioPharma 12,753,896 19.99 48.36
2018‑02‑12 SC 13D Nantucket Investments Ltd JAGX / Jaguar Animal Health 23,634,341 24.9 383.89
2018‑02‑09 SC 13D/A SCHULER JACK W QDEL / QUIDEL 4,383,734 12.9
2018‑02‑09 SC 13D/A HealthCare Ventures VIII, L.P. CBIO / Catalyst Biosciences 72,274 1.7 -93.24
2018‑02‑09 SC 13D/A Clarus Lifesciences I, L.P. VBIV / VBI Vaccines, Inc. 2,691,042 4.22 0.00
2018‑02‑09 SC 13D/A Clarus Lifesciences II, L.P. CATB / Catabasis Pharmaceuticals 2,768,258 11.99 0.38
2018‑02‑08 SC 13D/A STAFFORD JOHN S III PPHM / Peregrine Pharmaceuticals 2,977,260 6.6 -10.07
2018‑02‑07 SC 13D/A BRATTON DOUGLAS K JUNO / Juno Therapeutics 5,433,301 4.7 -28.77
2018‑02‑05 SC 13D/A Baker Brothers Advisors LP SGEN / Seattle Genetics 49,818,661 31.7 8.37
2018‑02‑02 SC 13D/A CELGENE CORP /DE/ JUNO / Juno Therapeutics 11,109,160 9.7 0.00
2018‑02‑02 SC 13D/A Phase4 Partners Ltd ALBO / Albireo Pharma 1,065,447 9.56 -8.58
2018‑02‑01 SC 13D/A Bp Peptides, Llc CAPS / Capstone Therapeutics 19,525,498 35.3 5.31
2018‑02‑01 SC 13D/A NOMIS BAY LTD. KBIO / KaloBios Pharmaceuticals 3,680,106 24.56 -1.05
2018‑02‑01 SC 13D/A AISLING CAPITAL III LP AGRX / Agile Therapeutics 1,855,905 3.8 0.00
2018‑02‑01 SC 13D/A AISLING CAPITAL III LP PTX / Pernix Therapeutics Holdings 221,809 1.9 -90.00
2018‑02‑01 SC 13D/A New Enterprise Associates 14, L.P. MIRN / Mirna Therapeutics 4,228,940 19.7 10.74
2018‑01‑31 SC 13D/A X-Master, Inc. ISCO / International Stem Cell 11,697,600 82.1 -91.54
2018‑01‑31 SC 13D/A Sarissa Capital Management LP APRI / Apricus Biosciences 2,120,361 13.5 -90.00
2018‑01‑29 SC 13D/A ORBIMED ADVISORS LLC NTLA / Intellia Therapeutics 2,537,684 5.99 0.00
2018‑01‑29 SC 13D/A DOMAIN PARTERS VII L P ESPR / Esperion Therapeutics 1,101,080 4.2 -43.76
2018‑01‑26 SC 13D/A ORBIMED ADVISORS LLC MIRN / Mirna Therapeutics 2,029,996 9.48 54.37
2018‑01‑26 SC 13D/A BLACK HORSE CAPITAL LP KBIO / KaloBios Pharmaceuticals 4,948,758 33.0 0.00
2018‑01‑26 SC 13D/A ORBIMED ADVISORS LLC STDY / SteadyMed 3,952,696 13.9 0.00